V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627656 | 330007047 | ECL02 | 1.5 | null | 5 | 2015-12-08 | TRIAL | 330007522 | 330003835 | 330007049 |
| 16627657 | 330007047 | EGU08 | 4800 | null | 1 | 2015-12-08 | MULTIPLE | 330007522 | 330003835 | 330007049 |
| 16627658 | 330007048 | EPH | 3200 | null | 2 | 2018-02-17 | NOT CHEMO | 330007522 | 330003835 | 330007050 |
| 16627659 | 330007048 | ETG | 150 | null | 1 | 2018-02-17 | TRIAL | 330007522 | 330003835 | 330007050 |
| 16627660 | 330007048 | EON | 100 | null | 1 | 2018-02-18 | IFOSFAMIDE | 330007522 | 330003835 | 330007050 |
| 16627661 | 330007048 | EKD02 | null | X731 | 5 | 2018-02-18 | NOT CHEMO | 330007522 | 330003835 | 330007050 |
| 16627662 | 330007048 | EJR | 2 | X724 | 1 | 2018-02-19 | VINCRISTINE | 330007522 | 330003835 | 330007050 |
| 16627663 | 330007048 | ENW | 135 | X724 | 1 | 2018-02-19 | CISPLATIN | 330007522 | 330003835 | 330007050 |
| 16627664 | 330007048 | ETG01 | 1350 | X721 | 1 | 2018-02-20 | FLUOROURACIL | 330007522 | 330003835 | 330007050 |
| 16627665 | 330007048 | EW100 | 8 | null | 2 | 2018-02-21 | NOT CHEMO | 330007522 | 330003835 | 330007050 |
| 16627666 | 330007054 | E1UZ0 | 290 | X729 | 5 | 2014-07-09 | BMS-986016 | 330007542 | 330003839 | 330007056 |
| 16627667 | 330007055 | EEI00 | 0 | X721 | 1 | 2015-09-25 | IFOSFAMIDE | 330007547 | 330003843 | 330007057 |
| 16627668 | 330007056 | EEI00 | 200 | X721 | 1 | 2015-09-13 | CYTARABINE | 330007554 | 330003844 | 330007058 |
| 16627669 | 330007056 | EEI00 | 0.75 | null | 1 | 2015-09-13 | NOT CHEMO | 330007554 | 330003844 | 330007058 |
| 16627670 | 330007056 | EEI00 | 3000 | x724 | 1 | 2015-09-13 | IFOSFAMIDE | 330007554 | 330003844 | 330007058 |
| 16627671 | 330007056 | EOI | 210 | X721 | 1 | 2015-09-20 | NOT CHEMO | 330007554 | 330003844 | 330007058 |
| 16627672 | 330007056 | EE813 | 20 | X724 | 1 | 2015-09-20 | DOXORUBICIN | 330007554 | 330003844 | 330007058 |
| 16627673 | 330007056 | EJR | 100 | X724 | 1 | 2015-09-20 | NOT CHEMO | 330007554 | 330003844 | 330007058 |
| 16627674 | 330007056 | EE813 | 1 | X721 | 1 | 2015-09-21 | NOT CHEMO | 330007554 | 330003844 | 330007058 |
| 16627675 | 330007056 | ERA20 | 136 | X724 | 1 | 2015-09-21 | CISPLATIN | 330007554 | 330003844 | 330007058 |
| 16627676 | 330007056 | EJU04 | 0 | null | 1 | 2015-09-21 | CISPLATIN | 330007554 | 330003844 | 330007058 |
| 16627677 | 330007056 | EZ1 | 1000 | X721 | 2 | 2015-09-23 | NOT CHEMO | 330007554 | 330003844 | 330007058 |
| 16627678 | 330007057 | EUZ | 4800 | null | 1 | 2016-10-30 | MESNA | 330007556 | 330008081 | 330007059 |
| 16627679 | 330007057 | EEI00 | 1.5 | X724 | 1 | 2016-10-30 | ETOPOSIDE | 330007556 | 330008081 | 330007059 |
| 16627680 | 330007057 | EXO | 3840 | null | 1 | 2016-10-30 | IFOSFAMIDE | 330007556 | 330008081 | 330007059 |
| 16627681 | 330007059 | EJRNN | 2320 | null | 1 | 2015-01-05 | IFOSFAMIDE | 330007561 | 330003847 | 330007061 |
| 16627682 | 330007059 | ECL01 | 170 | X721 | 1 | 2015-01-06 | TOPOTECAN | 330007561 | 330003847 | 330007061 |
| 16627683 | 330007061 | EUZ | 550 | X728 | 1 | 2016-08-20 | IFOSFAMIDE | 330007563 | 330003849 | 330007063 |
| 16627684 | 330007061 | E1UZ0 | 160 | X729 | 1 | 2016-08-27 | TRIAL | 330007563 | 330003849 | 330007063 |
| 16627685 | 330007061 | ED301 | 1.9 | X721 | 1 | 2016-08-27 | MESNA | 330007563 | 330003849 | 330007063 |
| 16627686 | 330007062 | EN710 | 4700 | X721 | 1 | 2014-01-22 | NOT CHEMO | 330007570 | 330003850 | 330007064 |
| 16627687 | 330007062 | EEI00 | 2750 | X721 | 1 | 2014-01-23 | NOT CHEMO | 330007570 | 330003850 | 330007064 |
| 16627688 | 330007063 | ED301 | 2960 | x724 | 1 | 2018-10-14 | ETOPOSIDE | 330007570 | 330003850 | 330007065 |
| 16627689 | 330007063 | EJR | 500 | null | 1 | 2018-10-14 | TOPOTECAN | 330007570 | 330003850 | 330007065 |
| 16627690 | 330007063 | EEI00 | 0 | null | 1 | 2018-10-14 | NOT CHEMO | 330007570 | 330003850 | 330007065 |
| 16627691 | 330007064 | E0N03 | 65 | null | 1 | null | ETOPOSIDE | 330007576 | 330012372 | 330007066 |
| 16627692 | 330007064 | EEI00 | 12 | X724 | 1 | null | TOPOTECAN | 330007576 | 330012372 | 330007066 |
| 16627693 | 330007064 | EUZ | 150 | null | 1 | null | NOT CHEMO | 330007576 | 330012372 | 330007066 |
| 16627694 | 330007064 | ECL02 | 140 | X724 | 1 | null | NOT MATCHED | 330007576 | 330012372 | 330007066 |
| 16627695 | 330007065 | EPH | 5520 | null | 1 | 2017-04-08 | PEMBROLIZUMAB | 330007579 | 330003851 | 330007067 |
| 16627696 | 330007065 | EEI00 | 500 | null | 1 | 2017-04-08 | TOPOTECAN | 330007579 | 330003851 | 330007067 |
| 16627697 | 330007065 | EGU08 | 5600 | null | 1 | 2017-04-11 | CETUXIMAB | 330007579 | 330003851 | 330007067 |
| 16627698 | 330007066 | EGU08 | 5520 | N\A | 1 | 2018-05-08 | NOT CHEMO | 330007579 | 330003852 | 330007068 |
| 16627699 | 330007066 | EK1EN | 1800 | X729 | 1 | 2018-05-09 | TRIAL | 330007579 | 330003852 | 330007068 |
| 16627700 | 330007072 | EPH | 3200 | X728 | 1 | 2014-02-11 | AZD9150 | 330007591 | 330003861 | 330007074 |
| 16627701 | 330007072 | E1UZ0 | 0 | X721 | 1 | 2014-02-12 | IFOSFAMIDE | 330007591 | 330003861 | 330007074 |
| 16627702 | 330007072 | EEI00 | 5800 | null | 1 | 2014-02-19 | METHOTREXATE | 330007591 | 330003861 | 330007074 |
| 16627703 | 330007072 | EOF | 500 | null | 1 | 2014-02-19 | AZD9150 | 330007591 | 330003861 | 330007074 |
| 16627704 | 330007073 | EPH | 3200 | X721 | 2 | 2018-01-21 | STEROID | 330007591 | 330003862 | 330007075 |
| 16627705 | 330007073 | Haqrsvarq | 178 | null | 2 | 2018-02-09 | MESNA | 330007591 | 330003862 | 330007075 |